Zisman
David A. Zisman, Agoura Hills, CA US
Patent application number | Description | Published |
---|---|---|
20100074887 | Methods for Treating and Diagnosing Fibrotic and Fibroproliferative Diseases - The present invention provides compositions and methods for diagnosing and treating fibrotic lung disease. | 03-25-2010 |
David A. Zisman, Santa Barbara, CA US
Patent application number | Description | Published |
---|---|---|
20120094305 | Methods For Treating And Diagnosing Fibrotic And Fibroproliferative Diseases - The present invention provides compositions and methods for diagnosing and treating fibrotic lung disease. In one embodiment the diagnostic method comprises determining the amount of circulating CXCL-12 in a patient relative to a control. | 04-19-2012 |
Erela Zisman, Richon Le Zion IL
Patent application number | Description | Published |
---|---|---|
20120238555 | Pharmaceutical composition containing irbesartan - This invention relates to pharmaceutical compositions containing irbesartan, providing oral formulations with a high relative amount or concentration of irbesartan. In one embodiment, the present invention provides an oral formulation of irbesartan containing greater than 70% w/w irbesartan. In another embodiment, the invention provides an oral formulation of irbesartan which exhibits a dissolution profile according to which greater than about 85% of the Irbesartan is dissolved within about 30 minutes using USP apparatus 2, placing the tablet in 1000 mL of 0.1N hydrochloric acid at 37° C. with paddle speed of 50 rpm. The formulation can optionally contain at least one additional active ingredient. | 09-20-2012 |
Erela Zisman, Rishon Le Zion IL
Patent application number | Description | Published |
---|---|---|
20090030057 | Pharmaceutical composition of telmisartan - The present invention provides a pharmaceutical composition of telmisartan comprising a) a telmisartan compound, b) a surfactant, c) a basic agent, and d) at least one diluent wherein the composition comprises less than 25% of water soluble diluents. The telmisartan compound is preferably present from about 12.5% to about 15.5%. At least one water insoluble diluent is preferred for use in the pharmaceutical composition in an amount from about 40% to about 70% of the total weight of the pharmaceutical composition. A preferred water insoluble diluent is microcrystalline cellulose. Also described are a pharmaceutical composition comprising telmisartan having a powder X-ray diffraction pattern, methods of preparing such pharmaceutical composition, and a crystalline form of Telmisartan. | 01-29-2009 |
Guy Zisman, Ramat-Gan IL
Patent application number | Description | Published |
---|---|---|
20150262080 | AUTOMATIC PRE-PROCESSING OF MODERATION TASKS FOR MODERATOR-ASSISTED GENERATION OF VIDEO CLIPS - A method includes defining multiple moderation tasks, which originate from respective textual articles that are to be automatically converted into respective video clips following moderation by human moderators. The moderation tasks are pre-processed, so as to predict success measures of the corresponding video clips. Delivery of the moderation tasks to the human moderators is prioritized based on the predicted success measures. | 09-17-2015 |
Lawrence S. Zisman, Slingerlands, NY US
Patent application number | Description | Published |
---|---|---|
20110117159 | INHIBITION OF JAK2 AS A TREATMENT OF PULMONARY ARTERIAL HYPERTENSION - The present invention relates to a method of treating pulmonary arterial hypertension by administering a therapeutically effective amount of a selective JAK2 inhibitor to a patient in need thereof. | 05-19-2011 |
20130136702 | METHOD OF NEUTRALIZING AN AEROSOL CONTAINING A COMPOUND OF INTEREST DISSOLVED IN A LOW PH SOLUTION - Systems and methods for neutralizing a solution comprising a compound of interest, comprising: aerosolizing a solution, wherein the solution is a low pH solution and comprises the compound of interest; contacting the aerosolized solution with ammonia vapor, wherein the ammonia vapor neutralizes at least a portion of said aerosolized solution; and removing at least some water from the neutralized aerosolized solution, wherein the neutralized aerosolized solution is at least partially dehydrated. | 05-30-2013 |
Lev Zisman, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20090154042 | OVER CURRENT PROTECTION METHOD AND DEVICE - An over current protection system, the system includes: a sampling rate unit, adapted to determine a sampling rate of at least one alternating input current in response to an alternating input current cycle duration; and a controller, adapted to receive samples of the at least one alternating input current and to initiate an appliance of an over current protection measure if at least one of the following conditions is fulfilled: an amplitude of an alternating input current exceeds a first threshold before magnitudes of multiple alternating input current samples exceed a second threshold; and magnitudes of multiple alternating input current samples exceed a third threshold, wherein the third threshold exceeds the first and second thresholds. | 06-18-2009 |